NEW APPROACHES TO ATHEROSCLEROSIS - AN OVERVIEW

被引:56
作者
MCCARTHY, PA
机构
[1] Medicinal Chemistry Department, Pfizer, Inc., Groton, Connecticut, 06340, Eastern Point Road
关键词
D O I
10.1002/med.2610130203
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
[No abstract available]
引用
收藏
页码:139 / 159
页数:21
相关论文
共 187 条
[1]   DISCOVERY, BIOCHEMISTRY AND BIOLOGY OF LOVASTATIN [J].
ALBERTS, AW .
AMERICAN JOURNAL OF CARDIOLOGY, 1988, 62 (15) :J10-J15
[2]  
ARAI M, 1988, ANN REP SANKYO RES L, V40, P1
[3]  
ARROWSMITH RJ, 1991, 9TH INT S ATH ROS, P185
[4]  
ASHTON MJ, 1991, 9TH INT S ATH ROS, P183
[5]   BILE-ACID SEQUESTRANTS [J].
AST, M ;
FRISHMAN, WH .
JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (02) :99-106
[6]   A POTENT, TISSUE-SELECTIVE, SYNTHETIC INHIBITOR OF HMG-COA REDUCTASE [J].
BALASUBRAMANIAN, N ;
BROWN, PJ ;
CATT, JD ;
HAN, WT ;
PARKER, RA ;
SIT, SY ;
WRIGHT, JJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (09) :2038-2041
[7]  
BARNHART RL, 1989, J LIPID RES, V30, P1703
[8]   SYNTHESIS AND BIOLOGICAL-ACTIVITY OF NEW HMG-COA REDUCTASE INHIBITORS .1. LACTONES OF PYRIDINE-SUBSTITUTED AND PYRIMIDINE-SUBSTITUTED 3,5-DIHYDROXY-6-HEPTENOIC (-HEPTANOIC) ACIDS [J].
BECK, G ;
KESSELER, K ;
BAADER, E ;
BARTMANN, W ;
BERGMANN, A ;
GRANZER, E ;
JENDRALLA, H ;
VONKEREKJARTO, B ;
KRAUSE, R ;
PAULUS, E ;
SCHUBERT, W ;
WESS, G .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (01) :52-60
[9]  
BELL FP, 1986, PHARM CONTROL HYPERL, P409
[10]  
BELL FP, 1991, 9TH INT S ATH ROS, P184